NYSE:G

Genpact Ltd (G)

29.25
+0.15 (0.52%)
as of Jul 2, 2026, 11:04:15 pm Market Open.
1 watching
0
Investor Insights
star iconJul 5, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Genpact Ltd, symbol G-N, has shown a solid earnings growth of 13% over the last 15 years, making it an attractive option in the banking and insurance services sectors. Despite this strong performance, the stock has experienced a decline of 20% this year largely attributed to fears surrounding artificial intelligence, which some analysts believe are unfounded. One expert has recommended covering the position due to the stock hitting a stop point at $43, while another has observed stagnation in its performance and suggested trailing the stop up to the same price. The stock currently trades at a price-to-earnings ratio of 9.7x and offers a free cash flow yield of 8.5%, indicating a potentially favorable investment outlook despite recent troubles.

consensus icon
Consensus
Sell
valuation icon
Valuation
Undervalued
review icon
Similar
Amdocs, DOX
BUY ON WEAKNESS
Might be a little high. Perfers in the low $20's.
PAST TOP PICK
(Was a top pick on April 10 up 7.5%) A little expensive now but they are still holding.
DON'T BUY
Will be hard to have more growth.
TOP PICK
A leader in all its products. Strong mngmnt.
DON'T BUY
Dominant in razor blades. Not a fan of mngmnt (old thinking?). Concerns on their business model. A one product company.
DON'T BUY
Management has stumbled.
Showing 16 to 21 of 21 entries